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Getting lamin B1 processed and organized
 
amins are the building blocks of the nuclear lamina, 
a complex polymer attached to the nuclear envelope that 
is thought to be important for nuclear stability, chromatin 
organization, and gene expression. On page 1223, Maske 
et al. identify the protease responsible for processing lamin 
B1, demonstrate the existence of a nuclear receptor specific 
for carboxymethylated lamin B1, and show that posttrans-
lational processing may control the localization of this lamin 
into subdomains within the nuclear envelope.
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After being farnesylated, the COOH-terminal CAAX 
domain of lamin 
B1 is cleaved by 
an endoprotease, 
and the new 
COOH terminus 
of the protein is 
then methylated 
by the enzyme 
Icmt. Using a 
monoclonal anti-
body that distin-
guishes proteolyzed 
from unproteolyzed 
lamin B1, the 
authors determined 
that proteolysis  Lamin B1 (yellow) is present in subdomains.
 
How to block botox
 
rom both chemical weapons inspectors 
and plastic surgeons, botulinum toxins 
are the focus of intense interest. But how 
do these incredibly toxic proteins get 
into cells? On page 1293, Dong et al. 
demonstrate that botulinum neurotoxin B 
(BoNT/B) uses the vesicle proteins synapto-
tagmin I and synaptotagmin II as cellular 
receptors, and that a fragment of synapto-
tagmin II can inhibit the toxin’s effects in 
animals.
Of the seven known neurotoxins ex-
pressed by 
 
Clostridium botulinum
 
, BoNT/
A, B, and E are the most common causes 
of botulism in humans and the major 
choices for both bioterrorist and pharma-
ceutical uses. In previous work, researchers 
identified several cellular proteins that 
can bind to these toxins, but there were 
conflicting data about which, if any, of 
the candidate receptors actually mediate 
F
 
specifically requires the CAAX endoprotease Rce1. Separate 
pools of farnesylated but unproteolyzed and proteolyzed 
but unmethylated lamin B1 appear in the nucleus, but 
retention of the protein’s COOH terminus in the nuclear 
envelope requires carboxymethylation, indicating that 
a nuclear receptor specifically recognizes the fully 
processed form of the protein. When farnesylation is 
inhibited, the residual mature form occupies defined 
subdomains of the nuclear lamina, and the authors have 
preliminary evidence that these subdomains are also present 
in untreated cells.
The results suggest that methylation of lamin B1 is a novel 
mechanism controlling the higher order organization of the 
nucleus. Lamin B1 interacts with chromatin, so the protein’s 
controlled localization to subdomains of the lamina might 
organize interacting chromatin into similar domains. The 
authors are now trying to identify the nuclear receptor for 
carboxymethylated lamin B1.
Since the well-known oncogene 
 
ras
 
 also requires processing 
of its CAAX domain, CAAX endoproteases, including Rce1, 
are popular targets for a new generation of experimental 
anticancer drugs. It was initially thought that CAAX processing 
was unnecessary in nondividing cells, but the new findings 
show that interfering with lamin B1 processing disrupts the 
integrity of the nuclear envelope, highlighting the potential 
for unforeseen side effects with the new drugs.
 
 
 
 
 
cellular entry. Once inside neurons, the 
toxins act as proteases to block exocytosis, 
ultimately leading to paralysis and death.
Using both loss-of-function and gain-of-
function approaches, Dong et al. show that 
synaptotagmin I or synaptotagmin II can 
act as a receptor to internalize BoNT/B 
into PC-12 cells. Fusion of synaptic vesicles 
with the plasma membrane, and thus display 
of vesicle proteins on the cell surface, 
occurs during excitation. Indeed, BoNT 
internalization is dependent on electrical 
activity in two different cell types. Fragments 
of synaptotagmin II effectively block the 
binding of BoNT/B to cultured cells and 
inhibit the activity of the toxin in mice, 
providing strong evidence that the interac-
tion is biologically relevant.
In the mouse experiments, an injection 
of synaptotagmin II fragments partially 
protected the animals against a subsequent 
challenge with BoNT/B. This is the first 
demonstration that a fragment from a 
bacterial toxin receptor can antagonize 
the toxin in animals. The authors are 
now defining the precise requirements for 
BoNT/B–synaptotagmin II interactions, 
and are also trying to identify the receptors 
for other 
 
Clostridium
 
 neurotoxins. 
 
 
Botulinum toxin (green) gets into cells 
thanks to synaptotagmin I (red).
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